Related references
Note: Only part of the references are listed.TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload
Valeska Bidault-Jourdainne et al.
JHEP REPORTS (2021)
Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study
Philip N. Newsome et al.
JOURNAL OF HEPATOLOGY (2020)
Assessment of the role of FGF15 in mediating the metabolic outcomes of murine vertical sleeve gastrectomy
Andriy Myronovych et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis
Yifeng Wang et al.
NATURE COMMUNICATIONS (2020)
Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice
Anuradha Rao et al.
FRONTIERS IN MEDICINE (2020)
FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis
Alex M. DePaoli et al.
DIABETES (2019)
Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis[S]
Mei Zhou et al.
JOURNAL OF LIPID RESEARCH (2019)
Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption
Young-Chae Kim et al.
GASTROENTEROLOGY (2019)
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis
Mary E. Rinella et al.
JOURNAL OF HEPATOLOGY (2019)
Bariatric surgery in patients with non-alcoholic fatty liver disease from pathophysiology to clinical effects
Tea L. Laursen et al.
WORLD JOURNAL OF HEPATOLOGY (2019)
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
Puneet Puri et al.
HEPATOLOGY (2018)
Fibroblast Growth Factor 15-Dependent and Bile Acid-Independent Promotion of Liver Regeneration in Mice
Bo Kong et al.
HEPATOLOGY (2018)
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
Phillipp Hartmann et al.
HEPATOLOGY (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial
Reza Nemati et al.
OBESITY SURGERY (2018)
Targeting FXR and FGF19 to Treat Metabolic DiseasesLessons Learned From Bariatric Surgery
Nadejda Bozadjieva et al.
DIABETES (2018)
Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives
Juan P. Arab et al.
HEPATOLOGY (2017)
Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
Mei Zhou et al.
JOURNAL OF HEPATOLOGY (2017)
Engineered FGF19 Eliminates Bile Acid Toxicity and Lipotoxicity Leading to Resolution of Steatohepatitis and Fibrosis in Mice
Mei Zhou et al.
HEPATOLOGY COMMUNICATIONS (2017)
Targeting the Enterohepatic Bile Acid Signaling Induces Hepatic Autophagy via a CYP7A1-AKT-mTOR Axis in Mice
Yifeng Wang et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice
Anuradha Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The Role of Cholesterol in the Pathogenesis of NASH
George N. Ioannou
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Brian C. Ferslew et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice
Patrice N. Mimche et al.
HEPATOLOGY (2015)
Comparison of Varicella-Zoster Virus RNA Sequences in Human Neurons and Fibroblasts
Nicholas L. Baird et al.
JOURNAL OF VIROLOGY (2014)
Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis
T. Hendrikx et al.
OBESITY REVIEWS (2014)
A nontumorigenic variant of FGF19 treats cholestatic liver diseases
Jian Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Bile Acid Signaling in Metabolic Disease and Drug Therapy
Tiangang Li et al.
PHARMACOLOGICAL REVIEWS (2014)
Regulation of Cholesterol and Bile Acid Homeostasis by the Cholesterol 7α-Hydroxylase/Steroid Response Element-Binding Protein 2/microRNA-33a Axis in Mice
Tiangang Li et al.
HEPATOLOGY (2013)
Glucose and Insulin Induction of Bile Acid Synthesis MECHANISMS AND IMPLICATION IN DIABETES AND OBESITY
Tiangang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys
Rama Pai et al.
TOXICOLOGICAL SCIENCES (2012)
Bile Acids Induce Inflammatory Genes in Hepatocytes A Novel Mechanism of Inflammation during Obstructive Cholestasis
Katryn Allen et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Role of integrins in fibrosing liver diseases
Eleonora Patsenker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Eric T. Sawey et al.
CANCER CELL (2011)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Fast and SNP-tolerant detection of complex variants and splicing in short reads
Thomas D. Wu et al.
BIOINFORMATICS (2010)
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Sushant Bhatnagar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Prevalence of nutrient deficiencies in bariatric patients
Seok Yee Toh et al.
NUTRITION (2009)
Bile acid levels are increased in the liver of patients with steatohepatitis
Marcia M. Aranha et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice
Steve S. Choi et al.
HEPATOLOGY (2006)
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Montserrat Mari et al.
CELL METABOLISM (2006)
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
T Inagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor
G Svegliati-Baroni et al.
GASTROENTEROLOGY (2005)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
Share Paper
